Amanda L Blackford
Overview
Explore the profile of Amanda L Blackford including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
136
Citations
3009
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stearns V, Chen R, Blackford A, Saylor E, Mull J, Folmer A, et al.
Breast Cancer Res Treat
. 2025 Jan;
PMID: 39869261
Purpose: Individuals with metastatic breast cancer (MBC) may live with their disease for many years. We initiated the Johns Hopkins Hope at Hopkins Clinic to assess the needs and optimize...
2.
Newton K, Jayasekera D, Blackford A, Behling C, Wilson L, Fishbein M, et al.
Hepatology
. 2025 Jan;
PMID: 39773889
Background And Aims: Longitudinal outcomes in children with metabolic dysfunction-associated steatotic liver disease (MASLD) remain unclear due to the absence of a standardized monitoring approach. This study aimed to (1)...
3.
Blackford A, Canto M, Goggins M
JAMA Oncol
. 2024 Nov;
11(1):79-80.
PMID: 39602156
No abstract available.
4.
Haverman L, Luijten M, Blackford A, Absolom K, Basch E, van Rossum M, et al.
Qual Life Res
. 2024 Oct;
33(12):3299-3307.
PMID: 39363117
Purpose: As patient-reported outcome measures (PROMs) are increasingly used in clinical practice for screening, monitoring, and management, the potential for response bias has been raised (e.g., over-reporting problems for attention,...
5.
Blackford A, Canto M, Dbouk M, Hruban R, Katona B, Chak A, et al.
JAMA Oncol
. 2024 Jul;
10(8):1087-1096.
PMID: 38959011
Importance: Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease with increasing incidence. The majority of PDACs are incurable at presentation, but population-based screening is not recommended. Surveillance of high-risk individuals...
6.
Balanchivadze N, Blackford A, Sedhom R, Broman K, Gupta A, Hussaini S
JAMA Otolaryngol Head Neck Surg
. 2024 Jun;
150(8):743-746.
PMID: 38935385
No abstract available.
7.
Steinman R, Gandy L, Qi H, Fertig E, Blackford A, Grandis J
Cancer Cell
. 2024 May;
42(5):723-726.
PMID: 38701793
Advances in biomedical research require a robust physician scientist workforce. Despite being equally successful at securing early career awards from the NIH as men, women MD-PhD physician scientists are less...
8.
Pollack C, Garrison V, Johnson T, Blackford A, Banks B, Howe W, et al.
J Natl Cancer Inst
. 2024 Apr;
116(8):1270-1279.
PMID: 38588578
Background: Lack of stable, affordable housing is an important social determinant of health. Federal housing assistance may buffer against housing vulnerabilities among low-income households, but research examining the association of...
9.
Ando Y, Dbouk M, Yoshida T, Saba H, Diwan E, Yoshida K, et al.
J Clin Oncol
. 2024 Mar;
42(18):2196-2206.
PMID: 38457748
Purpose: Circulating carbohydrate antigen 19-9 (CA19-9) levels reflect FUT3 and FUT2 fucosyltransferase activity. Measuring the related glycan, DUPAN-2, can be useful in individuals unable to synthesize CA19-9. We hypothesized that...
10.
Ando Y, Dbouk M, Blackford A, Yoshida T, Saba H, Diwan E, et al.
Ann Surg Oncol
. 2024 Feb;
31(5):2902-2912.
PMID: 38319515
Background: Cancer antigen 19-9 (CA19-9) is widely used as a marker of pancreatic cancer tumor burden and response to therapy. Synthesis of CA19-9 and its circulating levels are determined by...